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To determine molecular viral components which can induce innate immune responses in human peripheral blood
mononuclear cells (PBMC), we investigated the anti-neoplastic agent Newcastle disease virus (NDV) and its two spike
proteins hemagglutinin-neuraminidase (HN) and fusion protein (F). NDV was an excellent inducer in PBMC of IFN-
production and capable of inducing upregulation of plasma membrane expression of tumor necrosis factor related apoptosis
inducing ligand (TRAIL). Viral replication was not required for these responses because NDV inactivated for 5 min by UV was
as good as live NDV. NDV-modified and paraformaldehyde-fixed BHK cells could also trigger IFN- and TRAIL induction,
indicating that contacts of responder cells with NDV-modified cell surfaces are sufficient to induce these activities in PBMC.
Antibodies against HN but not F were able to block these responses. Finally we could show that HN but not F induced IFN-
and TRAIL in PBMC. This was possible through the use of respective gene transfectants generated with the help of Semliki
Forest virus (SFV) replicase-based DNA recombinant expression systems. Upon contact with BHK cells expressing HN but
not F at their cell surface, human PBMC produced IFN- and some cells, including monocytes and T lymphocytes,
upregulated cell surface TRAIL expression. © 2002 Elsevier Science (USA)INTRODUCTION
Most viruses induce type I interferon (IFN) responses
in infected individuals and in cells in culture. Freshly
isolated human peripheral blood mononuclear (PBM)
cells from healthy individuals contain a small fraction of
so-called natural interferon producing cells (NIPCs) (Sie-
gal et al., 1999; Kadowaki et al., 2000) capable of pro-
ducing high amounts of INF- upon contact with virus-
infected cells. IFN- and IFN- are interferon type I
glycoproteins of 143 and 145 amino acids, respectively.
They exert pleiotropic functions mediating resistance of
cells to virus infection, immune stimulation, and antitu-
mor effects. They can enhance the expression of class I
major histocompatibility complex molecules, stimulate
the activity of natural killer (NK) cells, modulate the pro-
duction of other cytokines, and drive the differentiation of
T cells toward a Th1 phenotype (Belardelli and Gresser,
1996). Many attempts have been made to define the
mechanism of IFN type I induction, but the molecular
determinants for this type of innate immune response
are not yet defined.
Here we studied Newcastle disease virus (NDV),
which is an avian paramyxovirus with a single-strand
119RNA of negative polarity, approximately 15 kb long and
coding mainly for six genes (3-NP-P-M-F-HN-L-5) (Na-
gai et al., 1989). The avirulent strain Ulster which we
used here was shown to replicate selectively in the
cytoplasm of tumor cells but not of normal cells (Schirr-
macher et al., 1999b). NDV Ulster was recently shown to
induce IFN- almost exclusively in a subset of PBMC
monocyte/dendritic-like cells which are negative for
FcR-I (CD64) and FcR-III (CD16) receptors (Grage-
Griebenow et al., 2001). NDV expresses two membrane
integrated viral spike proteins, the hemagglutinin-neura-
minidase (HN) and the fusion (F) protein, which enable
cell binding and infection. The HN of NDV (NDV-HN) is a
74-kDa membrane type II glycoprotein which protrudes
from the viral envelope or from the membrane of infected
cells and expresses on its extracellular domain both
hemagglutinin (HA) and neuraminidase (NA) activity. HN
plays a key role in mediating the attachment of the virus
to host cell receptors with terminal sialic acid. Due to its
agglutinating properties, the HN molecule could also
play a role in facilitating the contact and attachment
between infected cells and other cells. F protein of NDV
(NDV-F) is involved in the fusion of the viral and host cell
membrane, a prerequisite for viral cell entry.
Recombinant gene expression systems have been
used for identifying the interferon-inducing activity ofKey Words: Newcastle disease virus; IFN-; TRAIL; PBM
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of human parainfluenza virus type 4A had an ability to
induce IFN- in mouse spleen cells (Ito et al., 1994).
Isolated recombinant gp120 protein of HIV exhibited
some interferonogenic activity in human peripheral blood
mononuclear cells (PBMC) (Ankel et al., 1994, Capobian-
chi et al., 1992). The recombinant glycoprotein gD of
herpes simplex virus (HSV) is the major inducer of IFN
production and interacts with appropriate receptors on
IFN- producing cells (Ankel et al., 1998). The coexpres-
sion of M and E proteins of the corona virus transmissi-
ble gastroenteritis virus (TGEV) allowed the formation of
pseudoparticles, which exhibited an interferonogenic ac-
tivity similar to that of complete virions (Baudoux et al.,
1998a,b). To the best of our knowledge there is only
one description of Paramyxovirus surface proteins as
IFN- inducers in lymphoid cells. The authors found that
isolated Sendai virus HN protein was able to stimulate
the release of low IFN- titers in the supernatant of
mouse spleen cells (Ito and Hosaka, 1983; Mattana et al.,
1999).
In this article we used the efficient Semliki Forest
virus (SFV) expression vector for replicase-driven high
expression of NDV-derived HN or F genes in BHK
cells. We will show that HN but not the F protein of
NDV is capable of inducing a strong IFN- response in
human PBMC.
Tumor necrosis factor related apoptosis inducing li-
gand (TRAIL) is a type II integral membrane protein
belonging to the tumor necrosis factor (TNF) family,
which induces apoptotic cell death in a wide range of
tumor cells and virus-infected cells but generally not in
normal cells (Wiley et al., 1995; Pitti et al., 1996). Recently,
some results indicated a unique feature of type I IFNs to
enhance TRAIL expression on monocytes (Kayagaki et
al., 1999), a finding which may explain some of the
antiviral and antitumor effects of IFNs (Griffith et al.,
1999).
NDV is known as anti-neoplastic agent and is used in
the clinic for more than 30 years (Cassel and Garret,
1965, Nelson, 1999). NDV Ulster which is nonlytic has
been used successfully as vaccine adjuvant for postop-
erative active specific immunotherapy of breast cancer in
phase II clinical studies with the virus-modified live-cell
vaccine ATV-NDV (autologous tumor vaccine, NDV-mod-
ified) (reviewed in Schirrmacher et al., 1998). Because of
these findings, we were interested in studying the mo-
lecular mechanism of the antitumor activity of NDV.
In a previous study we demonstrated that NDV acti-
vates murine monocytes/macrophages toward anti-
tumor cytotoxic activity (Schirrmacher et al., 2000). Here
we will show that NDV and its molecular determinant
HN induces TRAIL expression at the cell surface of
human CD14 monocytes and CD3 T cells and IFN- in
PBMC.
RESULTS
Induction of IFN- and TRAIL in PBMC by NDV-Ulster
virions
Figure 1A shows the IFN- response of human PBMC
to increasing amounts of NDV Ulster. Twenty-four hours
after stimulation, the IFN titers in the culture medium
reached levels at about 450 pg/ml when using 10 to 25
hemagglutinating units (HU) of virus per 106 PBMC. From
1 to 10 HU there was a steady increase of the IFN-
response. Intensive UV treatment for 30 min, but not
standard UV inactivation for 5 min, destroyed most of the
virus potency to induce IFN- (Fig. 1). To verify the virus
specificity of the interferon response, we tested the pos-
sible inhibitory effect of mouse anti-NDV serum as well
as control nonimmune mouse serum and of two mono-
clonal anti-NDV antibodies. As shown in Fig. 1B, mouse
anti-NDV serum significantly blocked the IFN--inducing
potency of intact NDV in a dose-dependent manner,
whereas nonimmune mouse serum did not. A virus-
neutralizing HN specific monoclonal antibody (mAb)
(HN.B) also blocked IFN- induction by NDV. In contrast,
an mAb against the F protein (Icii) did not affect the IFN
response nor did normal IgG2a immunoglobulin isotype,
which was used as control (data not shown).
The induction of cell surface TRAIL expression by NDV
in human PBMC was studied next. Human PBMC were
either nontreated or treated with NDV and then cultured
for 24 h before they were stained with a biotin-conju-
gated anti-TRAIL antibody or a respective isotype control.
Immunolabeling was revealed by PE-conjugated strepta-
vidin and analyzed by flow cytometry. As shown in Fig.
2A, TRAIL was upregulated on NDV treated as compared
to nontreated PBMC. UV inactivation of NDV for 5 min
reduced its TRAIL-inducing activity partially and UV in-
activation for 30 min reduced it completely (Fig. 2A).
Gating on CD14 or CD3 subpopulations revealed that
NDV treatment of PBMC induced surface TRAIL expres-
sion on monocytes (Figs. 2B and 2C) and lymphocytes
(not shown; see also Fig. 5). TRAIL induction by NDV on
CD14 monocytes could be blocked nearly completely
by anti-HN mAb (Fig. 2C). TRAIL induction by NDV on
CD3 T cells was blocked to 50% by anti-HN mAb (data
not shown). In contrast, no reduction of TRAIL expression
was seen when using anti-F mAb for inhibition (Fig. 2C).
These results suggest that the HN glycoprotein of NDV is
involved in the upregulation of TRAIL expression on
monocytes and T lymphocytes in human PBMC.
Induction of IFN- and TRAIL in PBMC by NDV-
infected and fixed cells
To test the effect of virus-infected and fixed cells in-
stead of free virus on human PBMC, we selected BHK
cells because these cells themselves do not produce
INF- upon NDV infection. NDV-infected and uninfected
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BHK cells were first tested for cell surface viral protein
expression by FACScan analysis using mouse anti-NDV
serum or anti-HN and anti-F mAbs. Figure 3A shows that
NDV-infected BHK cells express HN and F. Viral antigen
density increased from 1 h (representing absorbed virus)
to 24 h (representing cell surface viral antigens produced
during virus replication). To determine the dose-re-
sponse curve of IFN- induction in PBMC by virus-in-
fected cells, BHK cells were infected for 1 or 24 h,
washed and fixed with paraformaldehyde, and then in-
creasing numbers of these cells were added to PBMC for
24 h coincubation. As shown in Fig. 3B, IFN- induction
increased linearly with increasing numbers of virus-in-
fected and fixed cells used for stimulation. There was no
major difference between infected cells and cells ex-
pressing adsorbed virus only.
We also tested the effect of cell surface absorbed
NDV-UV. The more virus that was used to modify the cell
surface (this was verified by an increase in mean fluo-
rescence intensity), the higher the IFN- response was
(data not shown). BHK cells without virus did not stimu-
late a response. The maximal IFN- response of 106
PBMC to 2  105 BHK cells modified with 300 HU
NDV-UV and fixed was about 100 pg/ml (data not shown).
The analogous response to BHK cells infected for 24 h
with live NDV and then fixed was 400 to 500 pg/ml (Fig.
3B). Neither virus-infected BHK cells alone nor PBMC
alone produced detectable IFN- (data not shown).
When PBMC were incubated with NDV-infected fixed
BHK cells in the presence of anti-NDV or control serum,
the interferon response could be specifically inhibited
(Fig. 4). Anti-HN mAb also suppressed the interferon
induction, although not completely, while anti-F mAb
showed no detectable inhibitory effect. These results
FIG. 1. (A) Dose-response curve for INF- induction by live NDV-Ulster virus in human PBMC. PBMC were cocultured for 24 h with the indicated
amounts of virus. The levels of IFN- in culture supernatants were determined by ELISA. (B) Effect of specific antiviral antibodies on IFN- induction
by NDV-Ulster in human PBMC. Serial dilutions of the indicated mAb (specific for the hemagglutinin protein (HN) (in HU per 106 PBMC) or for the fusion
protein of NDV) or of the indicated mouse sera specific for NDV were incubated with NDV (10 HU) for 1 h at room temperature before the mixture
was added to PBMC (1  106). Controls were without addition of mAb or antiserum or with the addition of naı¨ve mouse serum (diluted in the same
way as the mouse anti-NDV serum). After 24 h, the supernatants were collected and IFN- content measured by ELISA.
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again suggest that NDV and in particular the HN protein
is relevant for the interferon response.
We also investigated TRAIL expression in human
PBMC after incubation for 24 h with paraformaldehyde-
fixed NDV-infected or not infected BHK cells. As shown in
Fig. 5, TRAIL expression was upregulated on CD14
monocytes (A) and CD3 T cells (B) when stimulated with
fixed NDV-BHK cells in comparison to controls treated
with fixed noninfected BHK cells. Our results demon-
strate that not only free NDV virus but also NDV-infected
fixed cells can induce IFN- and TRAIL in human PBMC.
Induction of interferon- and TRAIL in PBMC by HN
but not F transfectants
To prove that the inducer of interferon in human PBMC
was the HN protein on the surface of NDV-modified BHK
cells, two efficient expression plasmids, pSFV-HN and
pSFV-F, were constructed including Semliki Forest virus
replicons to produce transient BHK transfectants for
IFN- induction. Immunofluorescence microscopy of
transfected cells revealed cell surface and cytoplasmic
staining of HN (A) and F (B) as can be seen in Figs. 6A
and 6B. Transfectants were also analyzed for cell surface
expression of HN or F protein by FACS. The HN trans-
fectants were specifically stained with anti-HN mAb,
while the F transfectants were specifically stained with
anti-F mAb (data not shown). For testing their capacity of
IFN induction, BHK cells were transfected by electropo-
ration with the recombinant plasmids pSFV-HN or
pSFV-F and incubated for 40 h to allow for gene expres-
sion. After fixation, the cell monolayers were incubated
for 24 h with human PBMC and human IFN- present in
the culture medium was quantified by ELISA (Fig. 7A). No
detectable IFN- was found in the culture fluids of PBMC
cocultured with BHK cells alone or BHK cells transfected
with the empty pSFV-vector. In contrast, PBMC produced
IFN- when cocultured with BHK cells transfected with
pSFV-HN recombinant plasmid, but not when cocultured
with BHK cells transfected with pSFV-F plasmid. The
maximal level of IFN- production at a BHK/PBMC ratio
of 1:5 was about 130 pg/ml.
We conclude that it is the HN and not the F protein of
NDV which induces the IFN- response in human PBMC.
This phenomenon appears to be independent of the
FIG. 2. Induction of TRAIL on human PBMC (A) and on gated CD14 monocytes (B, C) by NDV live or NDV-UV and effect of antiviral mAbs. (A) PBMCs
were either untreated or treated with NDV or NDV-UV (20 HU/107 PMBC) in 2 ml culture medium for 24 h. UV treatment of the virus was for either
5 or 30 min. The cells were then stained with biotinylated anti-TRAIL polyclonal antibody followed by PE-labeled streptavidin. Bold lines represent
staining with TRAIL antibody; dotted lines show background staining with naı¨ve control serum. (B) Histogram of the gated CD14 monocytes in PBMC.
For this purpose, the cells were stained with FITC-labeled anti-CD14 mAb. Bold line represents staining with this mAb and the dotted line shows
background staining with irrelevant isotype control FITC-labeled. (C) Effects of monoclonal antiviral antibodies on TRAIL expression by NDV-treated
CD14 cells. Anti-HN (HN.B) and anti-F (Icii) mAb were incubated with NDV (20 HU) for 1 h at room temperature before the mixture was added to
PBMCs. After 24 h incubation, similar stainings were performed as described for (A) and (B) and analyzed for gated monocytes. The percentage of
TRAIL-positive cells in gate M1 is indicated.
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cellular context of gene expression, since similar obser-
vations were made with transfected COS7 cells instead
of BHK cells (data not shown).
We also tested for a possible synergistic effect be-
tween HN and F proteins in the IFN- response of
human PBMC. For this purpose HN and F recombinant
plasmids were cotransfected into BHK cells. Immunoflu-
orescence staining revealed that both proteins were co-
expressed at the surface of the same cell (Fig. 7B).
Figure 7B shows that the cotransfection of HN and F did
not influence the level of IFN- production by PBMC.
Specific blocking experiments confirmed the previous
findings. Only anti-NDV serum and anti-HN mAbs could
block the response, while anti-F mAb, even in this con-
text, had no inhibitory effect.
We next tested whether transfected HN protein could
also upregulate TRAIL expression on human PBMC. The
test conditions were similar to those of Fig. 7. We found
that TRAIL was upregulated, as in Fig. 5B, on the surface
of CD3 T cells but not on CD14 monocytes when
PBMC were triggered by BHK cells transfected with
pSFV-HN. When the BHK cells were transfected with
pSFV-F, no upregulation of TRAIL could be observed
(data not shown).
In conclusion, we here demonstrate that HN but not F
protein of NDV induces the secretion of IFN- and the
upregulation of TRAIL expression in human PBMC. A
contact of membrane-expressed HN with responding
cells in PBMC appears to be sufficient for this response.
DISCUSSION
A large number of studies show the importance of
innate nonspecific host defense mechanisms for early
viral resistance (Biron et al., 1989; Hednerzak and Mora-
FIG. 3. IFN--inducing activity of fixed NDV-infected BHK cells in human PBMC. BHK cells were trypsinized and treated with NDV-Ulster (10 HU/106)
for 1 h (for virus binding) or they were treated for 24 h at 37°C (for infection during 24 h). After incubation, the cells were washed twice in PBS and
fixed on ice with 1% paraformaldehyde for 15 min and washed again with PBS to remove the paraformaldehyde. (A) The viral proteins expressed at
the BHK cell surface were determined after virus binding (1 h) or after virus replication (24 h) by flow cytometry using mouse polyclonal anti-NDV
serum or the mAbs anti-HN (HN.B) and anti-F (Icii) and the PE-conjugated anti-mouse IgG (see Materials and Methods). Dotted lines correspond to
uninfected BHK cells treated in the same way. (B) Isolated PBMC (1  106) were incubated at 37°C for 1 or 24 h in 0.4 ml of RPMI–10% FCS with the
NDV modified fixed BHK cells in increasing concentrations and the release of IFN- into the supernatant was determined by ELISA.
FIG. 4. Blocking capacity of specific antiviral antibodies on IFN-
induction in PBMC by paraformaldehyde-fixed NDV modified during
24 h BHK cells. The treated BHK cells (1  105) were first incubated
with the indicated specific antibodies (diluted 1:10, 1:100, and 1:1000 in
RPMI–10% FCS) for 1 h and then coincubated with 1 106 PBMC in 0.4
ml RPMI–10% FCS for 24 h at 37°C. Controls were done without
addition of any antibody or with addition of an irrelevant mAb or naı¨ve
mouse serum. The levels of IFN- in the culture supernatant were
determined by ELISA.
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han, 1994). Adaptive humoral and cellular immune re-
sponses are essential for the clearance and ultimate
resolution of viral infections. The IFN system, especially
IFN- and -, plays an important role in innate and
adoptive immune responses to viral infection. For exam-
ple, IFN- has been shown to promote differentiation of
CD4 T cells toward the Th1 type, the major producers of
IFN- and IL-2 (Sandberg et al., 1989; Ito, 1994). In addi-
tion, recent studies showed that type I IFNs caused
proliferation of CD8 T cells in an antigen-independent
manner and survival of CD8 T cells responding to spe-
cific antigens (Sandberg et al., 1989). In general, RNA-
containing viruses are very good IFN- inducers and
NDV is one of the most efficient virus in doing so (Ho,
1973).
Many attempts have been made to define molecular
mechanisms of IFN induction. Based on the virus and the
cells used, two main interferon-inducing systems can be
distinguished: one is viral nucleic acid and the other is
viral glycoproteins. The latter triggers interferon induc-
tion by membrane–membrane interactions via lectin-like
carbohydrate interaction (Ito, 1994). Besides, a combina-
tion of the two mechanisms has been proposed (Mori-
waki et al., 1998).
Type I IFNs seem to be involved also in the upregula-
tion of TRAIL expression by human monocytes (Kayagaki
et al., 1999; Henderzak and Morahan, 1994; and our
unpublished data). This might explain why HN not only
induced IFN- but concomitantly also TRAIL. We here
demonstrate for the first time TRAIL induction by NDV not
only in human monocytes but also in human lympho-
cytes.
The effect of UV treatment of NDV on its capacity to
induce interferon- and TRAIL deserves discussion. In-
tensive UV treatment for 30 min, but not standard UV
inactivation for 5 min, destroyed most of the virus po-
tency to induce IFN- (Fig. 1) or TRAIL (Fig. 2). Prolonged
UV treatment is associated with development of heat. We
reported before that NDV is very sensitive to heat treat-
ment, which destroys its cell binding ability possibly by
protein denaturation (Schirrmacher et al., 1997). The de-
stroyed cell binding capacity could thus account for the
loss of functional activity. In a previous study (Sen-
newald, 2000) we found for human macrophages that
incubation with 200 UI/ml IFN- for 16 h induced about
the same level of surface TRAIL expression as 20 HU/ml
live NDV or of 5 min UV-inactivated NDV. UV treatment of
reovirus (Winship and Marcus, 1980) or rotavirus
(McKimm-Breschkin and Holmes, 1982) also did not
block totally the production of interferon-. These obser-
vations support the view that viral double-stranded RNA
(dsRNA) is not the only inducer of interferon and that
membrane proteins could be involved in this process as
well.
With regard to IFN- induction in human PBMC by
NDV, it has been previously suggested that this is a
FIG. 5. Upregulation of TRAIL on CD14 monocytes and CD3 T cells by coculture of PBMC for 24 h with fixed NDV infected (during 24 h) or
noninfected BHK cells. Staining and gating were performed similar to that described for Fig. 3C, except that the staining of the T cells was done with
FITC-labeled CD3 mAb. A small shift to the right in mean fluorescence intensity of TRAIL staining in comparison to controls (with uninfected BHK cells)
indicates NDV-mediated upregulation of TRAIL on human monocytes (A) and T lymphocytes (B).
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complex process involving the HN protein, uncleaved F
protein precursor, and a component of the M protein
fraction (Wertz et al., 1994). In the present work we
constructed recombinant plasmids by inserting the
cDNA of the HN and F gene of NDV separately into a
highly efficient SFV-based expression vector system. We
clearly demonstrate that human PBMC produced IFN-
only when cocultured with BHK cells transfected with
recombinant HN and not when cocultured with BHK cells
transfected with recombinant F plasmid or vector alone.
Therefore, we conclude that the interaction between HN
glycoproteins and receptors at PBMC cell surfaces is
sufficient to trigger interferon induction.
In this study, we also observed that the induction of
IFN- in PBMC by recombinant HN protein expressed at
the BHK cell surface is lower by 70% than the inducing
activity by NDV-infected and fixed BHK cells. There are
several possible explanations. This observed difference
may be due to the fact that the avidity of interactions with
viral host cell receptors may be different when using
complete virions or recombinant single molecules only.
For instance, the ability of HIV virions to trigger IFN-
production in PBMC was reported to be much higher
than that of soluble gp120 protein (Ofek et al., 1995). The
IFN- inducing activity of the M protein of TGEV virus
was proposed to depend upon its incorporation into a
polymeric, specifically organized structure (Baudoux et
al., 1998a). Densely arranged and ordered repetitive
structures are hallmarks of infectious agents, including
viruses. We also cannot exclude the existence of other
FIG. 6. Cytoplasmic expression analyzed by immunofluorescence microscopy of HN (A) and F (B) protein by HN or F-transfected BHK cells. BHK
cells were transfected with pSFV-HN (A) or pSFV-F (B) plasmids by electroporation and then incubated in complete medium for 40 h. Cells were
stained with anti-HN (A) or anti-F mAbs (B) and then with FITC-conjugated goat anti-mouse IgG as described under Materials and Methods. (C)
Immunofluorescence analysis for coexpression of NDV HN and F. BHK cells were cotransfected with pSFV-HN and pSFV-F as described above. The
monolayers of transfected cells were stained with specific anti-HN mAb and anti-F mAb and then with PE-labeled anti-mouse IgG 2a and
FITC-conjugated anti-mouse IgG 1, respectively.
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IFN-inducing molecules, for example, the matrix (M) pro-
tein which is located on the inner side of the lipid mem-
brane or of double-stranded RNA from the cytoplasma.
Recent studies showed that most enveloped viruses
stimulate IFN- production primarily in rare (about
1/1000) but highly productive cells of human PBMC (Ro¨nn-
blom and Alm, 1982; Cederblad and Alm, 1990). These
cells are negative for lineage-specific markers of T, B, NK
cells, and monocytes and have been termed NIPC for
natural interferon producing cells (Svensson et al., 1996).
It is likely that the IFN- response reported here for the
HN glycoprotein of NDV is also mediated by these NIPC.
As dendritic-like cells these NIPC were suggested to
connect innate with adaptive T cell responses (Kadowaki
et al., 2000).
Although envelope glycoproteins seem necessary for
induction of IFN- by viruses, the nature of their interac-
tion with the NIPC is unknown. To date, an interaction via
a lectin-like activity has been proposed as a common
and central event for triggering IFN production (Tormo et
al., 1999). A large number of virus glycoproteins possess
hemagglutinating activity. When cells are infected, viral
hemagglutinin functions as a primary viral attachment
factor. Its binding to cellular receptors is the first step of
infection. These properties are similar to those of plant
lectins which also have hemagglutinating activity and
can induce interferon in leukocytes. The HN glycoprotein
of paramyxoviruses is a carbohydrate-binding protein
which recognizes terminal N-acetyl neuraminic acid res-
idues (sialic acids) attached to galactosamine. Hence
the HN protein can be thought of as a viral lectin (Haas
et al., 1998).
FIG. 7. (A) Induction of IFN- in PBMC by BHK cells transfected with HN but not F expression plasmids. 1  106 PBMCs were cocultured for 24 h
with the indicated amounts of BHK cells which had been transfected with HN or F recombinant DNA, empty vector, or without vector and precultured
for 40 h to allow for gene expression. The supernatants of the cocultures were collected and IFN- production determined by ELISA. (B) Induction
of IFN- in PBMC by BHK cells transiently coexpressing NDV HN and F proteins. IFN- induction in PBMC by BHK cells cotransfected with HN and
F recombinant DNA and effect of specific antibodies on the IFN response. Cotransfected BHK with pSFV-HN and -F plasmids cells were incubated
for 24 h with human PBMC in the presence or absence of specific anti-HN or anti-F mAbs or of mouse anti-NDV serum or naı¨ve serum as indicated.
The IFN- production in the culture fluid was determined by ELISA.
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Lectin receptors exist on most, if not all, cells of the
mononuclear phagocyte system and mediate endocyto-
sis and phagocytosis. Sialyl oligosaccharides are recog-
nized as receptors by parainfluenza and influenza vi-
ruses (Masuda et al., 1999). Important components on
cell surface membranes such as major histocompatibility
complexes (MHC) can also act as viral lectin receptors
(Tormo et al., 1999). Human membrane cofactor protein
(CD46) serves as lectin receptor for measles virus
(Naniche et al., 1993), CD4 has receptor function for HIV
(Tough et al., 1996) and the intercellular adhesion mole-
cule 1 (ICAM-1) has receptor function for the major sub-
group of human rhinoviruses (Hewat et al., 2000). Most of
these virus receptors are involved in cell–cell adherence
and in cell–cell recognition. Thus it is highly probable
that binding of viral proteins to cellular receptors induces
some cell functions. For example, Francis and Meltzer
(1993) have shown that IFN- induction by HIV-1 requires
gp120–CD4 interactions but not viral replication. Re-
cently, culture-derived DCs were also shown to express
a lectin receptor, the mannose receptor (MR). Further
studies implicated the MR as an important receptor for
recognition of enveloped viruses by DC and the subse-
quent stimulation of IFN- production by these viruses
(Milone and Fitzgerald-Bocarsly, 1998). Antiserum to the
MR was able to inhibit HSV, vesicular stomatitis virus,
and HIV-induced IFN- production, but failed to inhibit
the IFN- response induced by Sendai virus. Which re-
ceptor may be involved in the induction of IFN- by
NDV-HN glycoprotein is still unclear. Recent reports in-
dicated that influenza hemagglutinin can enhance lysis
of virus-infected target cells by NK cells, as well as
activate NK cells directly via triggering the receptor
NKp46 (Mandelboim et al., 2001). Recognition by NKp46
was required to lyse cells expressing the corresponding
viral glycoproteins. This also appeared to be a lectin-
carbohydrate recognition system since viral glycoprotein
binding required the sialylation of NKp46 oligosaccha-
rides. This is consistent with the known sialic acid bind-
ing capacity of viral H or HN glycoproteins.
Further identification of the signals transduced by viral
glycoprotein–cellular receptor interactions in innate im-
mune responses is an obvious goal of future studies. To
date, it has been demonstrated that the transcription
factors of the interferon regulation factor (IRF) family play
a critical role in the activation of IFN genes in the innate
immune response to virus infection. NDV activates IRF-3,
IRF-5, and IRF-7. IRF-5 appears to possess unique fea-
tures different from IRF-3 and IRF-7 (Barnes et al., 2001).
It shows cell-type restricted expression and is activated
by NDV but not by Sendai virus. NDV activation leads to
IRF-5 phosphorylation and translocation to the nucleus
where distinct IFN- genes (in particular IFN A8) are
induced (Barnes et al., 2001). A relationship between
IFN- and TRAIL induction may exist due to molecular
cross talks between the TRAIL and the interferon signal-
ing pathways (Kumar-Sinha et al., 2002). Recently a
dsRNA binding protein called PACT has been identified
which is likely to play an important regulatory role
(Iwamura et al., 2001). We are thus not far from under-
standing the molecular components and mechanisms of
an innate and immediate response of human cells to
NDV. This response, characterized by induction of IFN
and TRAIL, likely contributes to the antitumor properties
of NDV.
MATERIALS AND METHODS
Virus, cells, and antibodies
The avirulent strain NDV-Ulster 2C was propagated in
embryonated chicken eggs, harvested from the allantoic
fluid, purified as described previously (Schirrmacher et
al., 1999b), and cryopreserved in aliquots at 70°C. The
virus was quantified by the hemagglutination test in
which one hemagglutination unit is defined as the small-
est virus concentration leading to visible sheep erythro-
cyte agglutination. UV-NDV represents UV-inactivated vi-
rus. For this purpose, NDV-Ulster (6000 HU/ml in PBS)
was exposed in an open Petri dish for 5 or 30 min at a
distance of 7 cm to a UV lamp (245 nm, 2 mW/cm2).
Cells from a baby hamster kidney cell line (BHK; ATCC,
Rockville, MD) were maintained in modified Eagle’s me-
dium (MEM) supplemented with 5% fetal calf serum
(FCS), 20 mM L-glutamine, and antibiotics (all reagents
purchased from Gibco Life Technologies, Karlsruhe, Ger-
many).
Polyclonal antisera and mAbs to NDV were used in
this study. The mouse IgG2a anti-HN mAb HN.B and the
mouse IgG1 anti-F mAb Icii were kindly provided by Dr.
Iorio (Iorio et al., 1989). Polyclonal anti-NDV serum was
prepared by immunizing mice four times sc with 40,000
HU/ml NDV-Ulster mixed 1:1 with incomplete Freund’s
adjuvant (Sigma Chemical Co., Munich, Germany). Pre-
immune serum and the antiserum obtained were heat
inactivated (for 45 min at 56°C), aliquoted, and stored at
20°C. As secondary antibodies for immunofluores-
cence staining of NDV proteins, rat anti-mouse IgG2a-
PE, rat anti-mouse IgG1-FITC, and goat anti-mouse
IgG-PE (all from Southern Biotechnology Associates, Bir-
mingham, AL) were used. Anti-CD14-FITC, anti-CD3-
FITC, and isotype control mAbs were purchased from
Pharmingen, Becton Dickinson, Heidelberg, Germany.
Preparation of PBMC
Human PBMC were obtained by Ficoll–Hypaque (Bio-
chrom, Berlin, Germany) centrifugation of anticoagulant
(sodium citrate, 3.8%)-supplemented venous blood from
healthy individuals. The interface cells were washed
twice with PBS and adjusted to 107 per milliliter in RPMI
culture medium supplemented with 10% FCS (both re-
agents from Gibco Life Technologies). Only PBMC with a
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cell viability  95% (trypan blue exclusion method) were
cultivated in cell culture plates at 37°C in a humidified
incubator with 5% CO2.
NDV modification of BHK cells
BHK cells were trypsinized and infected with NDV
Ulster at a concentration of 16 HU/1 106 cells. After 1 h
coincubation, the cells were washed twice in PBS and
cultured for 24 h in fresh RPMI medium with 10% FCS at
37°C. In other experiments, the infected cells were di-
rectly further incubated for 24 h without washing. After-
ward, the cells were washed twice with PBS, fixed on ice
with 1% paraformaldehyde (Sigma) for 15 min, and
washed again twice in PBS to remove the paraformalde-
hyde. The expression of NDV surface proteins was then
analyzed by antibody staining and flow cytometry.
Construction of HN and F high expression plasmids
and transfection of BHK cells
The SFV-based DNA eukaryotic expression vector
pBK-T-SFV used in this study has been described else-
where (J. Zeng, P. Fournier, and V. Schirrmacher, unpub-
lished observations). Briefly, a cDNA fragment containing
the NDV-HN gene inserted in the JMPpSFV1 plasmid
(Meanger et al., 1997) between the BssHII site and the
ApaI site (JMPpSFV-HN) was cut with PuvI and BglII.
Then this fragment was inserted into the PuvI and BglII
sites of the pBK-T-SFV vector to construct the HN clone
pBKT-SFV-HN. For constructing a cDNA clone of the
NDV-F gene, a cDNA fragment which contains the NDV-F
gene inserted in the JMPpSFV-F plasmid between the
BssHII site and the ClaI site was cut with SpeI and AgeI
and then subcloned into the SpeI and AgeI sites of the
pBKT-SFV vector.
The recombinant plasmids (pBTK-SFV-HN, here des-
ignated pSFV-HN, and pBTK-SFV-F, here designated
pSFV-F) were introduced into BHK cells by the electro-
poration method. BHK cells were grown to 50% conflu-
ence, trypsinized, washed once with MEM plus FCS,
once with PBS, and resuspended at 107 cells/ml in PBS
without Ca2 and Mg2. An amount of 0.5 ml of the cells
was transferred at room temperature to a 0.4-cm elec-
trocuvette (Bio-Rad, Munich, Germany); 10–15 g plas-
mid DNA was then added and incubated at room tem-
perature for 10 min. The cells then received one electro-
pulse at 0.4 kV and 960 F using the Gene Pulser
apparatus from Bio-Rad and were further incubated at
room temperature for another 10 min. Then cells from
one cuvette were plated on six 6-cm plates and incu-
bated at 37°C. At 40–48 h after transfection, the expres-
sion of HN or F at the cell surface of live transfected cells
was assessed by FACScan analysis. Moreover, the
transfected cells were cocultured with PBMC and tested
for their capacity of IFN- induction. For the cotransfec-
tion, 5 g pSFV-HN DNA and 5 g pSFV-F DNA were
used together. For control, BHK cells were transfected
with 10 g DNA of the empty vector pBK-T-SFV (here
designated pSFV).
Immunofluorescence microscopy
BHK cells were transfected as described above and
plated on 35-mm-diameter plates containing glass cov-
erslips. The cells were washed twice with PBS contain-
ing 1.5% BSA and 0.02% sodium azide and then fixed with
cold acetone for at least 5 min. Afterward, the cells were
incubated at 4°C in PBS containing 3% BSA and 0.02%
sodium azide (both from Sigma) and mouse anti-HN or
anti-F mAb (10 g/ml) for 1 h. Then the cells were
washed three times with ice-cold PBS containing BSA
and azide (both from Sigma) and incubated on ice with
PBS containing BSA, azide, and FITC- or PE-conjugated
anti-mouse IgG for 1 h. Cells were washed with cold PBS
containing BSA and azide (both from Sigma) and visual-
ized in a Nikon fluorescence microscope (Nikon, Du¨s-
seldorf, Germany) using the appropriate filters. Photo-
graphs were taken and analyzed.
FACS analysis of transfected cells and determination
of neuraminidase activity
BHK cells transfected with NDV-HN or -F cDNA were
detached from culture plates by treatment with trypsin-
EDTA (Gibco Life Technologies), washed twice, and in-
cubated for 30 min on ice with anti-HN mAb (HN.B) or
anti-F mAb (Icii) or with PBS or isotype control mAb as
control. After two other washing steps, the T cells were
incubated with PE-conjugated anti-mouse IgG (Southern
Biotechnology Assoc.) for 30 min and then washed once
in PBS before being analyzed with a FACScan fluores-
cence analyzer (Becton Dickinson). In this analysis, the
relative fluorescence intensity per cell was calculated
from 10,000 cells. Viral cell surface expressed antigens
were stained by indirect immunofluorescence as de-
scribed for immunofluorescence microscopy.
Neuraminidase (NA) activity of the HN protein at the
cell surface was determined by a fluorimetric method
(Luther et al., 1983). The transfected cells were coincu-
bated at 107 cells/ml with 2% sheep red blood cells
(SRBC; obtained from Oxoid, Wesel, Germany) for 1 h at
37°C. NA activity unmasks receptors for peanut aggluti-
nin (PNA) on the surface of the SRBC. These are then
stained with 50 l FITC-labeled PNA (Sigma) (3.1 ng/ml)
in PBS for 20 min at room temperature. After two further
washings, the SRBC were analyzed by FACScan as above.
The transfected BHK cells were excluded from the anal-
ysis by their different size and granularity.
Induction of the production of soluble IFN- and of
cell surface TRAIL molecules on human PBMC
Human PBMC were tested as responder cells to pro-
duce IFN- by overnight incubation at 37°C with NDV in
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24-well microtiter plates. They were incubated at a final
concentration of 2.5  106 cells per milliliter in a total
volume of 0.4 ml with NDV or UV-NDV at various dilu-
tions, as indicated under Results. In some experiments,
PBMC were incubated with a defined number of NDV
modified or transfected BHK cells that had been fixed
with 1% paraformaldehyde. Cell supernatants were col-
lected, centrifuged to remove cells, and stored at 20°C
before testing IFN- content by ELISA. FACS analysis of the
PBMC allowed the detection of surface TRAIL molecules.
For inhibition studies, interferon inducer (NDV virions
or NDV-infected BHK cells) and specific antibodies were
mixed and preincubated for 30 min at 37°C before PBMC
were added. Then the incubation was continued over-
night before analysis of the IFN- induction in the super-
natant and TRAIL expression at the surface of the PBMC.
IFN- immunoassay
A specific enzyme-linked immunosorbent assay
(ELISA) for human IFN- was performed according to the
manufacturer’ s instructions (MedSystems Diagnostics
GmbH, Vienna, Austria).
TRAIL detection assay
TRAIL molecules were detected by flow cytometry
using biotinylated purified immunoglobulins from a poly-
clonal goat anti-human TRAIL serum (RD Systems, Wies-
baden, Germany) and streptavidin-PE (Pharmingen Bec-
ton Dickinson).
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